Anti CD40 HPV vaccine - EnnoDC
Alternative Names: Anti-CD40 HPV vaccine - EnnoDC; CD40.HVac; CD40HVac; HPV anti-CD40 HPV vaccineLatest Information Update: 07 Mar 2025
At a glance
- Originator Vaccine Research Institute
- Developer EnnoDC
- Class Papillomavirus vaccines; Protein vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Human papillomavirus infections